There was some very exciting news announced earlier this week from researchers at the Masonic Cancer Center, University of Minnesota, that generated considerable attention throughout the scientific community and within the general public and national media.
Masonic Cancer Center researchers uncovered a human enzyme responsible for causing DNA mutations found in the majority of breast cancers. The discovery of this enzyme – called APOBEC3B – may change the way breast cancer is diagnosed and treated.
The findings from a team of researchers led by Reuben Harris, Ph.D., associate professor of biochemistry, molecular biology and biophysics and a researcher within the Masonic Cancer Center, University of Minnesota, are published in the latest edition of Nature.
“We strongly believe this discovery will change the way mutations in cancer are viewed and, hopefully, it will allow cancer researchers to develop new treatment approaches that can prevent these mutations before they become harmful,” said Harris.